ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2017 > ESMO Preceptorship on Immuno-Oncology 2017
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page


Chair: R.A. Stahel, CH


  Comprising plenary lectures by a multidisciplinary faculty of international experts and case-based sessions, ESMO Preceptorship courses offer an enriched learning experience, thanks to their small size and emphasis on interaction with fellow participants and faculty.
The courses are designed primarily for medical and clinical oncologists and aim to educate participants about the current standards of care. They are particularly suitable for young oncologists and for general oncologists wishing to update their knowledge. Each course is accredited with ESMO-MORA CME (8-10 points).


ESO is pleased to announce that a limited number of travel grants are made available on a competitive basis to non-ESMO members interested in attending the ESMO Preceptorship on Immuno-Oncology courses in 2016.

The Preceptorship courses are scheduled as follows and the travel grant application by non-ESMO members should be submitted by the following deadline:

 4-5 July 2016, Siena, Italy   
Chairs: M. Maio, IT - R.A. Stahel, CH - S. Peters, CH
Application deadline: 15 May
Further information available here

 30 September - 1 October 2016, Amsterdam, The Netherlands   
Chair: R.A. Stahel, CH

Application deadline: 4 August
Further information available here

 2-3 November 2016, Zurich, Switzerland   
Chair: R.A. Stahel, CH

Application deadline: 8 September
Further information available here
 2-3 February 2017, Madrid, Spain    
Chair: R.A. Stahel, CH

Application deadline: 4 December

Further information and the programme is posted at


The ESMO Preceptorship on Immuno-Oncology Madrid February 2017 was designed for understanding the basics of tumour immunology; learning about the essentials of immunotherapies and their applications in cancer medicine; learning about the status of development and clinical experience of immunotherapy in different tumour types.

Presentations of the ESMO Preceptorship on Immuno-Oncology Madrid February 2017 are available to ESMO members according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Further information can be obtained here.